Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk

Figure 1 Flow cytometric analysis of platelet membrane glycoproteins, platelet-derived microparticles and platelet-leukocyte aggregates. A: Flow cytometric analysis of membrane-bound glycoproteins. Analysis of each GP was performed on particles of FSC/SSC of platelets (R2) expressing CD36 (R1); B: Beads for gating of microparticles of 0.5 μm (left population), 0.9 μm (right population) and 3 μm (upper right population). Same gating strategy was used to identify PMPs of 0-0.5 μm (R1 and R3 not R2), 0.5-0.9 μm (R1 and R2 and R3) or PMPs in general (R1 and R3); C: Platelet-leukocyte aggregates calculated for lymphocytes (red), monocytes (green) and granulocytes (blue).